Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up – Still a Buy?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report) gapped up prior to trading on Monday . The stock had previously closed at $5.29, but opened at $5.56. Aveanna Healthcare shares last traded at $5.44, with a volume of 45,420 shares changing hands.

Wall Street Analyst Weigh In

AVAH has been the topic of several recent research reports. UBS Group lifted their target price on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a report on Friday, March 14th. Truist Financial lowered their price objective on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research report on Monday, January 6th.

Read Our Latest Stock Report on Aveanna Healthcare

Aveanna Healthcare Stock Down 1.4 %

The stock’s 50-day simple moving average is $4.69 and its 200 day simple moving average is $4.95. The firm has a market cap of $1.07 billion, a P/E ratio of -16.18 and a beta of 2.25.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the company’s stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64. Following the transaction, the insider now owns 1,453,948 shares in the company, valued at approximately $8,011,253.48. This represents a 4.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 7.80% of the company’s stock.

Institutional Trading of Aveanna Healthcare

Large investors have recently made changes to their positions in the company. KLP Kapitalforvaltning AS bought a new position in Aveanna Healthcare in the fourth quarter worth approximately $35,000. BNP Paribas Financial Markets acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth approximately $35,000. Tower Research Capital LLC TRC grew its position in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after purchasing an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd increased its stake in Aveanna Healthcare by 321.4% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock valued at $54,000 after purchasing an additional 9,000 shares in the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new position in Aveanna Healthcare during the fourth quarter worth $57,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Read More

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.